A recent study comparing 33 children with MS to 54 children with MOGAD, and 29 healthy controls, observed significantly higher levels of adiponectin in the serum of MS patients compared to both the MOGAD and healthy control patients (p = 0.02) (59). This evidence concerns the gene ADIPOQ and myeloid sarcoma.